Literature DB >> 16251246

Effect of lipid modification on progression of coronary calcification.

Peter A McCullough1.   

Abstract

Coronary artery calcification (CAC) reflects the anatomic presence of coronary atherosclerosis and the relative burden of coronary artery disease (CAD). Higher levels of CAC are seen in the presence of CAD risk factors, older age, and chronic kidney disease. The lipid profile (primarily low HDL cholesterol, elevated triglycerides, elevated LDL cholesterol, and elevated total cholesterol) are important factors in the calcification process. The annual progression of CAC can be reduced from 25 to 30% to 0 to 6% with LDL cholesterol reduction caused by statins and possibly sevelamer. At treated LDL cholesterol levels somewhere below 100 mg/dl, several sources of data suggest the anatomic burden of CAD, including CAC, regresses. Additional supportive studies indicate that carotid intimal medial thickness and the volume of coronary atheroma also can be reduced by LDL cholesterol reduction in concert with elevation of HDL cholesterol. This article reviews the data in support of altering the natural history of CAC with lipid modification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251246     DOI: 10.1681/ASN.2005060664

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.

Authors:  James A MacKenzie; Kristen A Roosa; Brooks B Gump; Amy K Dumas; Kestutis G Bendinskas
Journal:  Appl Physiol Nutr Metab       Date:  2010-08       Impact factor: 2.665

2.  Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.

Authors:  Haiqing Shen; Coleen M Damcott; Evadnie Rampersaud; Toni I Pollin; Richard B Horenstein; Patrick F McArdle; Patricia A Peyser; Lawrence F Bielak; Wendy S Post; Yen-Pei C Chang; Kathleen A Ryan; Michael Miller; John A Rumberger; Patrick F Sheedy; John Shelton; Jeffrey R O'Connell; Alan R Shuldiner; Braxton D Mitchell
Journal:  Arch Intern Med       Date:  2010-11-08

3.  Atherogenic indices in pseudoexfoliation syndrome.

Authors:  Enver Mirza
Journal:  Eye (Lond)       Date:  2019-07-05       Impact factor: 3.775

4.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

5.  Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants?

Authors:  Fida Bacha; Daniel Edmundowicz; Kim Sutton-Tyrell; SoJung Lee; Hala Tfayli; Silva A Arslanian
Journal:  Diabetes Care       Date:  2014-09       Impact factor: 19.112

6.  Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.

Authors:  Kentaro Watanabe; Hideki Fujii; Keiji Kono; Shunsuke Goto; Shinichi Nishi
Journal:  BMC Cardiovasc Disord       Date:  2020-01-30       Impact factor: 2.298

7.  Expression of NPP1 is regulated during atheromatous plaque calcification.

Authors:  Yvonne Nitschke; Simone Hartmann; Giovanni Torsello; Rüdiger Horstmann; Harald Seifarth; Gabriele Weissen-Plenz; Frank Rutsch
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.